SGLT-2-inhibitors in patients with cardiac wild-type ATTR-amyloidosis

被引：0

作者：

Barzen, Gina ^{[1
,2
]}

Kugel, Elias ^{[2
]}

Roemmelt, Constantin ^{[2
]}

Mattig, Isabel ^{[2
]}

Hahn, Katrin ^{[2
]}

Spethmann, Sebastian ^{[1
]}

机构：

[1] Free Univ Berlin, Berlin, Germany

[2] Charite, Deutsch Herzzentrum, Dept Cardiol Angiol & Intens Care Med, Berlin, Germany

来源：

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：S12 / S12

页数：1

共 50 条

[1] A clinical and instrument-based investigation of large and small nerve fibre impairment impacts on patients' management in ATTR-amyloidosis and provides new insights in wild-type ATTR-amyloidosis
Papagianni, A.
Ihne, S.
Zeller, D.
Stoerk, S.
Sommer, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 237 - 237
[2] Rare ATTR wild-type cardiac amyloidosis after kidney transplantation
Zepeda-Quiroz, Ivan
Michel-Vasquez, Ana
Aparicio-Ortiz, Alexis D.
Cortez-Flores, Brenda Guadalupe
Cabello-Ganem, Aldo
Soto-Abraham, Virgilia
Berrios-Barcenas, Enrique Alexander
Rodriguez-Castellanos, Francisco Eugenio
Flores-Gama, Cesar
Espinola-Zavaleta, Nilda
JOURNAL OF NUCLEAR CARDIOLOGY, 2023, 30 (06) : 2828 - 2832
[3] Rare ATTR wild-type cardiac amyloidosis after kidney transplantation
Ivan Zepeda-Quiroz
Ana Michel-Vasquez
Alexis D. Aparicio-Ortiz
Brenda Guadalupe Cortez-Flores
Aldo Cabello-Ganem
Virgilia Soto-Abraham
Enrique Alexander Berrios-Bárcenas
Francisco Eugenio Rodríguez-Castellanos
Cesar Flores-Gama
Nilda Espinola-Zavaleta
Journal of Nuclear Cardiology, 2023, 30 : 2828 - 2832
[4] Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center Experience
Mints, Yuliya Y.
Berk, John L.
Connors, Lawreen
Doros, Gheorghe
Gopal, Deepa M.
Kataria, Shivangi
Lohrmann, Graham
Pipilas, Alexandra R.
Ruberg, Frederick L.
Siddiqi, Omar K.
CIRCULATION, 2019, 140
[5] Wild-type ATTR amyloidosis of the prostate: a case review
Sterrett, Russell
McCurdy, Arleigh
JOURNAL OF CLINICAL UROLOGY, 2023, 16 (06) : 688 - 690
[6] Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy
Paton, D. M.
DRUGS OF TODAY, 2019, 55 (12) : 727 - 734
[7] Developing a framework to optimise the ongoing assessment of ATTR-amyloidosis in patients with a cardiac phenotype
Rapezzi, C.
Coelho, T.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 148 - 148
[8] Association between spinal stenosis and wild-type ATTR amyloidosis
Godara, Amandeep
Riesenburger, Ron I.
Zhang, Diana X.
Varga, Cindy
Fogaren, Teresa
Siddiqui, Nauman S.
Yu, Anthony
Wang, Andy
Mastroianni, Michael
Dowd, Richard
Nail, Tara J.
McPhail, Ellen D.
Kurtin, Paul J.
Theis, Jason D.
Toskic, Denis
Arkun, Knarik
Pilichowska, Monika
Kryzanski, James
Patel, Ayan R.
Comenzo, Raymond
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (04): : 226 - 233
[9] Temporal Trends of Wild-type Attr Amyloidosis in the Transthyretin Amyloidosis Outcomes Survey
Nativi-Nicolau, Jose
Siu, Alfonso
Dispenzieri, Angela
Maurer, Mathew S.
Rapezzi, Claudio
Kristen, Arnt
Garcia-Pavia, Pablo
LoRusso, Samantha
Waddington-Cruz, Marcia
Lairez, Olivier
Witteles, Ronald
Chapman, Doug
Rill, Denise
Kiszko, Jan
Amass, Leslie
Grogan, Martha
JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S82 - S82
[10] The Journey To Diagnosis Of Wild-type Attr Amyloidosis: A Path With Multisystem Involvement
Karam, Chafic
Summers, Catherine
Moffitt, Colleen
Merkel, Madeline P.
Kochman, Fran M.
Weijers, Laure S.
Schurer, Marieke
Mason, Nicola
Finkel, Muriel
Hanna, Mazen
JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 704 - 704

← 1 2 3 4 5 →